Connect with us

Hi, what are you looking for?

Thursday, Aug 11, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Allied Corp. finishes exporting the first Colombia-grown flower shipment to international markets

The company has other 4 exports planned for Australia, Switzerland and United States.

Allied Corp. enters sales agreement with Brazilian medical distributor
Photo via Allied.

Allied Corp. (OTCQB: ALID) says it is the first cannabis operator to successfully send a commercial shipment of Colombia-grown dried flower to other international markets.

On Wednesday, the Kelowna-based company said that after many levels of regulatory inspections, analyses, discussions and questions the first export approval by the Colombian government came this month.

The first monthly shipment will go to the United States and involves 500 kilograms with the first 200 shipped on June 28. The cultivar shipped has 18 per cent CBD with THC levels that are under 0.3 per cent THC.

Read more: Allied Corp. enters sales agreement with Brazilian medical products distributor

Read more: Allied Corp. to send €1M of cannabis to Australian partner

In addition to the shipment, Allied has submitted other export applications to the controlled substance office in Colombia for export approvals for many additional shipments:

  • 1000 kilograms destined for Australia of which an initial order of 200kgs is being processed for Australia via Switzerland.
  • 7100 kilograms order for a Swiss company based out of Zurich.
  • 1000 kilograms recurring monthly order for a U.S. multi-state operator.
  • 50 kilograms recurring monthly order for Australia.

Allied currently has 5800 THC plants waiting to be harvested and another 15,000 clones of THC plants created for multiple batches to fulfill its 2022 export quota. The THC flower harvest will begin on or about August 15 and will be available for sale in September 2022.

Read more: Allied Corp. begins exports of Colombia-grown dried flower to Australia and US

Read more: Colombia releases awaited guidelines for cannabis commercialization

“We did it! We are the first company to ship a commercial shipment of dried cannabis to an international market,” Allied CEO Callum Hughes said in a statement.

Hughes said that the accomplishment speaks to the quality of his team, and most importantly the company’s product.

“Two years of genotyping and phenotyping has led us to our current genetics that are proving to be superior in terms of cannabinoid profiles, as well as being pest and mold resistant,” he explained.

He added that while this has not been an easy challenge, the company will continue to fulfill the additional signed purchase contracts and grow its international relationships with companies all over the world.

In April this year, the Colombian government enacted the new legislation allowing dried cannabis exports which prompted many multinational companies to apply for export permits.

Besides Allied, other companies taking steps to export dried flower include the Florida-headquartered Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ:CLVRW) also has its primary operations in Colombia and said it expects to export milled cannabis flower by the third quarter of 2022 and high THC flower before the end of the year.

Toronto-headquartered cannabis operator PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) has also signed a sales deal through its subsidiary PharmaCielo Colombia Holdings S.A.S. with a Germany-based independent pharmaceutical wholesaler Greenstein Germany GmbH.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

CBD

New inhalable drug containing CBD designed for efficacious treatment of brain injuries

Business

In July last year, the company received a pharmaceutical Drug Establishment License from Health  Canada

Industry update

Canadian company set to focus clinical trials down under, announces regulatory update

Business

This is the second product being developed by the pharmaceutical using PharmaCielo's APIs